Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9273288

Pseudoinfectious flavivirus and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9272028

Norovirus vaccine formulations

Takeda Vaccines, Inc. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9267112

Adenovirus isolated from Titi Monkeys

The Regents of the University of California · Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9260414

Inhibitors of hepatitic C virus

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9254316

Adenoviral vector-based malaria vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9248179

Pan-lyssavirus vaccines against rabies

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9249473

Compositions and methods for the identification of inhibitors of retroviral infection

TRANA DISCOVERY, INC. · Granted Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243230

Construct for producing empty virus capsids

The Pirbright Institute · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238800

Avian adenoassociated virus and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238799

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

granted patent

US 9233131

Mutant adeno-associated virus virions and methods of use thereof

The Regents of the University of California · Granted Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9222142

Adenoviruses and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9216214

Replication-competent adenoviral vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9212168

Hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9211323

Compositions and methods for administration of vaccines against dengue virus

Takeda Vaccines, Inc. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9205073

Method for treating virus infection using derivative of aniline

China Medical University · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206159

Piperazine-piperidine compounds as hepatitis C virus inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198927

Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198959

Adenovirus vaccine vector and methods of use

Regents of the University of Minnesota · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9200282

Compositions and methods for inhibiting expression of an RNA from west nile virus

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9193740

Bismacrocyclic compounds as hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9193769

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9193956

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California · Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted